Altimmune Inc (NASDAQ: ALT) kicked off on Monday, up 4.13% from the previous trading day, before settling in for the closing price of $5.81. Over the past 52 weeks, ALT has traded in a range of $5.14-$11.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 104.92% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -10.70%. With a float of $76.21 million, this company’s outstanding shares have now reached $77.01 million.
In an organization with 59 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -740.0%, operating margin of -515860.0%, and the pretax margin is -475295.0%.
Altimmune Inc (ALT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Altimmune Inc is 1.04%, while institutional ownership is 53.08%. The most recent insider transaction that took place on Mar 17 ’25, was worth 5,784. In this transaction Director of this company bought 1,000 shares at a rate of $5.78, taking the stock ownership to the 1,000 shares. Before that another transaction happened on Mar 13 ’25, when Company’s Chief Financial Officer bought 10,000 for $5.20, making the entire transaction worth $51,996. This insider now owns 10,000 shares in total.
Altimmune Inc (ALT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.61% during the next five years compared to 3.48% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Take a look at Altimmune Inc’s (ALT) current performance indicators. Last quarter, stock had a quick ratio of 13.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23296.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.71 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.06 million. That was inferior than the volume of 2.58 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 77.72%. Additionally, its Average True Range was 0.41.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 15.12%, which indicates a significant decrease from 89.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.11% in the past 14 days, which was lower than the 82.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.33, while its 200-day Moving Average is $6.93. However, in the short run, Altimmune Inc’s stock first resistance to watch stands at $6.20. Second resistance stands at $6.35. The third major resistance level sits at $6.54. If the price goes on to break the first support level at $5.86, it is likely to go to the next support level at $5.67. Assuming the price breaks the second support level, the third support level stands at $5.52.
Altimmune Inc (NASDAQ: ALT) Key Stats
The company with the Market Capitalisation of 465.93 million has total of 77,014K Shares Outstanding. Its annual sales at the moment are 20 K in contrast with the sum of -95,060 K annual income. Company’s last quarter sales were recorded 10 K and last quarter income was -23,180 K.
